Howard Horn
2019
In 2019, Howard Horn earned a total compensation of $2.2M as Chief Financial Officer at Vir Biotechnology.
Compensation breakdown
| Non-Equity Incentive Plan | $174,720 |
|---|---|
| Option Awards | $1,614,687 |
| Salary | $413,333 |
| Other | $11,200 |
| Total | $2,213,940 |
Horn received $1.6M in option awards, accounting for 73% of the total pay in 2019.
Horn also received $174.7K in non-equity incentive plan, $413.3K in salary and $11.2K in other compensation.
Rankings
In 2019, Howard Horn's compensation ranked 5,409th out of 13,971 executives tracked by ExecPay. In other words, Horn earned more than 61.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,409 out of 13,971 | 61st |
Division Manufacturing | 2,020 out of 5,695 | 65th |
Major group Chemicals And Allied Products | 718 out of 2,194 | 67th |
Industry group Drugs | 602 out of 1,880 | 68th |
Industry Biological Products, Except Diagnostic Substances | 140 out of 389 | 64th |
Source: SEC filing on April 6, 2020.
Horn's colleagues
We found two more compensation records of executives who worked with Howard Horn at Vir Biotechnology in 2019.